(NASDAQ: SENS) Senseonics Holdings's forecast annual revenue growth rate of 21.2% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.32%.
Senseonics Holdings's revenue in 2026 is $60,011,000.On average, 9 Wall Street analysts forecast SENS's revenue for 2026 to be $3,589,657,128, with the lowest SENS revenue forecast at $3,355,306,115, and the highest SENS revenue forecast at $3,779,033,344. On average, 10 Wall Street analysts forecast SENS's revenue for 2027 to be $5,334,690,211, with the lowest SENS revenue forecast at $4,462,694,084, and the highest SENS revenue forecast at $7,293,476,835.
In 2027, SENS is forecast to generate $5,586,516,206 in revenue, with the lowest revenue forecast at $4,745,744,969 and the highest revenue forecast at $7,391,533,944.